Changes of the human gut microbiome induced by a fermented milk product

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Veiga, Patrick ^a   Pons, Nicolas ^b   Agrawal, Anurag ^c   Oozeer, Raish ^a   Guyonnet, Denis ^a   Brazeilles, Rémi ^e   Faurie, Jean Michel ^a   Van Hylckama Vlieg, Johan E T ^a   Houghton, Lesley A ^c,d   Whorwell, Peter J ^c   Ehrlich, S Dusko ^b,f   Kennedy, Sean P ^b  

^a DANONE RESEARCH   (France)

^b University of Paris Saclay   (France)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MAYO CLINIC   (United States)

^e C2R   (France)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID DERIVATIVE; PROBIOTIC AGENT; RNA 16S;

BIFIDOBACTERIUM; BILOPHILA; DAIRY PRODUCT; DIET; FECES; FOOD CONTROL; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IRRITABLE COLON; LACTOBACILLUS DELBRUECKII; LACTOCOCCUS LACTIS; METABOLISM; MICROBIOLOGY; MICROFLORA; STOMACH; STREPTOCOCCUS THERMOPHILUS;

BIFIDOBACTERIUM; BILOPHILA; BUTYRATES; CULTURED MILK PRODUCTS; DIET; FECES; FOOD MICROBIOLOGY; HUMANS; IRRITABLE BOWEL SYNDROME; LACTOBACILLUS DELBRUECKII; LACTOCOCCUS LACTIS; MICROBIOTA; PROBIOTICS; RNA, RIBOSOMAL, 16S; STOMACH; STREPTOCOCCUS THERMOPHILUS;

EID: 84921396255     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06328     Document Type: Article

References (58)

1. Prajapati, J. B. & Nair, B. M. The history of fermented foods in Handbook of Fermented Functional Foods (ed. Farnworth, E, R), pp. 1-25. (CRC Press, Boca Raton, New York, , London, Washington DC, 2013).
2. Charbonneau, D., Gibb, R. D. & Quigley, E. M. M. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic. Gut Microbes 4, 201-211 (2013).
3. Kajander, K. et al. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment. Pharmacol. Ther. 26, 463-473 (2007).
4. McNulty, N. P. et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci. Transl. Med. 3, 106ra106 (2011).
5. Michail, S. & Kenche, H. Gut microbiota is not modified by randomized, double-blind, placebo-controlled trial of VSL#3 in diarrhea-predominant irritable bowel syndrome. Probiotics Antimicrob. Proteins 3, 1-7 (2011).
6. Lahti, L. et al. Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. PeerJ 1, e32 (2013).
7. Smith, C. J. & Osborn, A. Advantages and limitations of quantitative PCR (Q-PCR)-based approaches in microbial ecology. FEMS Microbiol. Ecol. 67, 6-20 (2009).
8. Janda, J. & Abbott, S. L. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: Pluses, perils, and pitfalls. J. Clin. Microbiol. 45, 2761-2764 (2007).
9. Zoetendal, E., Rajilic-Stojanovic, M. & de Vos, W. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605-1615 (2008).
10. Petrosino, J. F., Highlander, S., Luna, R. A., Gibbs, R. A. & Versalovic, J. Metagenomic pyrosequencing and microbial identification. Clinical Chemistry 55, 856-866 (2009).
11. Paliy, O. & Agans, R. Application of phylogenetic microarrays to interrogation of human microbiota. FEMS Microbiol. Ecol. 79, 2-11 (2012).
12. Lepage, P. et al. A metagenomic insight into our gut's microbiome. Gut 62, 146-158 (2013).
13. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65 (2010).
14. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
15. Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546 (2013).
16. Karlsson, F.H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99-103 (2013).
17. Canavan, C., West, J. & Card, T. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 6, 71 (2014).
18. Agrawal, A. et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment. Pharmacol. Ther. 29, 104-114 (2008).
19. Rochet, V. et al. Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product - A randomised study in healthy adults. J. Mol. Microbiol. Biotechnol. 14 , 128-136 (2008).
20. Collado, M. C., Moreno, Y., Cobo, J. M., Mateos, J. A. & Hernandez, M. Molecular detection of Bifidobacterium animalis DN-173010 in human feces during fermented milk administration. Food Res. Int. 39, 530-535 (2006).
21. Tatusov, R. L., Koonin, E. V. & Lipman, D. J. A genomic perspective on protein families. Science 278, 631-637 (1997).
22. Marchler-Bauer, A. et al. CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res. 39, D225-D229 (2011).
23. Duncan, S. H., Louis, P. & Flint, H. J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 70, 5810-5817 (2004).
24. Jumas-Bilak, E. et al. Acidaminococcus intestini sp. nov., isolated from human clinical samples. J. Mol. Microbiol. Biotechnol. 57, 2314-2319 (2007).
25. Louis, P. & Flint, H. J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 294, 1-8 (2009).
26. Prabhu, R., Altman, E. & Eiteman, M. A. Lactate and acrylate metabolism by Megasphaera elsdenii under batch and steady-state conditions. Appl. Environ. Microbiol. 78, 8564-8570 (2012).
27. Goker, M. et al. Complete genome sequence of Odoribacter splanchnicus type strain (1651/6). Stand. Genomic Sci. 4, 200-209 (2011).
28. Stanton, T. B. et al. Recognition of two new species of intestinal spirochetes: Serpulina intermedia sp. nov. and Serpulina murdochii sp. nov. Int. J. Syst. Bacteriol. 47, 1007-1012 (1997).
29. Scott, K. P. et al. Whole-genome transcription profiling reveals genes up-regulated by growth on fucose in the Human gut bacterium Roseburia inulinivorans. J. Bacteriol. 188, 4340-4349 (2006).
30. Van den Abbeele, P. et al. Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium Cluster IX. Appl. Environ. Microbiol. 76, 5237-5246 (2010).
31. Lillehoj, E. P., Kim, B. T. & Kim, K. C. Identification of Pseudomonas aeruginosa flagellin as an adhesin for Muc1 mucin. Am. J. Physiol. -Lung C. 282, L751-L756 (2002).
32. Wiencek, K. M., Klapes, N. A. & Foegeding, P. M. Hydrophobicity of Bacillus and Clostridium spores. Appl. Environ. Microbiol. 56, 2600-2605 (1990).
33. Oelgeschlager, E. & Rother, M. Carbon monoxide-dependent energy metabolism in anaerobic bacteria and archaea. Arch. Microbiol. 190, 257-269 (2008).
34. Zhu, X., Fan, W. G., Li, D. P., Kung, H. & Lin, M. C. Heme oxygenase-1 system and gastrointestinal inflammation: A short review. World J. Gastroentero. 17, 4283-4288 (2011).
35. Winter, S. E., Lopez, C. A. & Baeumler, A. J. The dynamics of gut-associated microbial communities during inflammation. Embo Rep. 14, 319-327 (2013).
36. Metchnikoff, E. The Prolongation of Life: Optimistic Studies (G.P. Putnam's Sons, New York, NY, 1908).
37. Veiga, P. et al. A Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. P. Natl. Acad. Sci. USA 107, 18132-18137 (2010).
38. Duncan, S. H. et al. Contribution of acetate to butyrate formation by human faecal bacteria. Br. J. Nutr. 91, 915-923 (2004).
39. David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563 (2014).
40. Devkota, S. et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nature 487, 104-108 (2012).
41. Martinez, I., Kim, J., Duffy, P. R., Schlegel, V. L. & Walter, J. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS ONE 5 (11), e15046 (2010).
42. Baron, E. J. Bilophila wadsworthia: a Unique Gram-negative Anaerobic Rod. Anaerobe 3, 83-86 (1997).
43. Soret, R. et al. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterol. 138, 1772-1782 (2010).
44. Fukumoto, S. et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J. Physiol. -Reg. I. 284, R1269-R1276 (2003).
45. Vanhoutvin, S. A. L. W. et al. The effects of butyrate enemas on visceral perception in healthy volunteers. Neurogastroentero. Motil. 21, 952-e76 (2009).
46. Chassard, C. et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment. Pharmacol. Ther. 35, 828-838 (2012).
47. Blachier, F. et al. Luminal sulfide and large intestine mucosa: friend or foe? Amino Acids 39 , 335-347 (2010).
48. Matsunami, M. et al. Luminal hydrogen sulfide plays a pronociceptive role in mouse colon. Gut 58, 751-761 (2009).
49. Kajander, K. et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Alimentary Pharmacology & Therapeutics 27, 48-57 (2008).
50. Saulnier, D.M. et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterol. 141, 1782-1791 (2011).
51. Marteau, P., Guyonnet, D., Lafaye de Micheaux, P. & Gelu, S. A randomized, double - blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I - 2494 in healthy women reporting minor digestive symptoms. Neurogastroentero. Motil. 25, 331-e252 (2013).
52. Matsuki, T., Watanabe, K., Fujimoto, J., Takada, T. & Tanaka, R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl. Environ. Microbiol. 70, 7220-7228 (2004).
53. Pons, N. et al. Meteor, a platform for quantitative metagenomic profiling of complex ecosystems. Journés Ouvertes en Biologie, Informatique et Mathématiques http://www.jobim2010.fr/sites/default/files/presentations/27Pons.pdf (2010). Date accessed (31/07/2014).
54. Chervaux, C. et al. Genome sequence of the probiotic strain Bifidobacterium animalis subsp. lactis CNCM I-2494. J. Bacteriol. 193, 5560-5561 (2011).
55. Letunic, I., Yamada, T., Kanehisa, M. & Bork, P. iPath: interactive exploration of biochemical pathways and networks. Trends Biochem. Sci. 33, 101-103 (2008).
56. Kobayashi, K. et al. Essential Bacillus subtilis genes. P. Natl. Acad. Sci. USA 100, 4678-4683 (2003).
57. Huson, D. H., Auch, A. F., Qi, J. & Schuster, S. C. MEGAN analysis of metagenomic data. Genome Res. 17, 377-386 (2007).
58. Molly, K., Vande, W. M. & Verstraete, W. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl. Microbiol. Biotechnol. 39, 254-258 (1993).